EU PHARMACEUTICAL NEWS IN BRIEFS
February 2nd, 2011
BY KEITH NUTHALL
THE EUROPEAN Medicines Agency (EMA) has issued new guidance on making stem cell-based medicines, covering the different types of stem cells used and advising on regularising manufacturing processes and resulting products - http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500101692
Other EU pharmaceutical news in briefs:
*EMA has released its first opinion regarding a clinical biomarker undergoing public consultation - this biomarker is supposed to identify patients who can be recruited for clinical trials of ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.